Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Arcus Biosciences (RCUS) EPS (Basic) (2017 - 2025)

Historic EPS (Basic) for Arcus Biosciences (RCUS) over the last 9 years, with Q3 2025 value amounting to -$1.27.

  • Arcus Biosciences' EPS (Basic) fell 2700.0% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$3.44, marking a year-over-year decrease of 920.63%. This contributed to the annual value of -$3.14 for FY2024, which is 2431.43% up from last year.
  • Latest data reveals that Arcus Biosciences reported EPS (Basic) of -$1.27 as of Q3 2025, which was down 2700.0% from -$1.14 recorded in Q1 2025.
  • In the past 5 years, Arcus Biosciences' EPS (Basic) ranged from a high of $4.04 in Q4 2021 and a low of -$1.27 during Q3 2025
  • For the 5-year period, Arcus Biosciences' EPS (Basic) averaged around -$0.7, with its median value being -$1.03 (2023).
  • Data for Arcus Biosciences' EPS (Basic) shows a peak YoY increase of 56436.78% (in 2021) and a maximum YoY decrease of 380000.0% (in 2021) over the last 5 years.
  • Quarter analysis of 5 years shows Arcus Biosciences' EPS (Basic) stood at $4.04 in 2021, then tumbled by 123.02% to -$0.93 in 2022, then dropped by 16.13% to -$1.08 in 2023, then rose by 3.4% to -$1.04 in 2024, then dropped by 21.73% to -$1.27 in 2025.
  • Its last three reported values are -$1.27 in Q3 2025, -$1.14 for Q1 2025, and -$1.04 during Q4 2024.